BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.54M | 46.95M | 48.87M | 49.00M | 50.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.54M | 46.95M | 48.87M | 49.00M | 50.31M |
| Cost of Revenue | 35.84M | 37.38M | 39.73M | 41.80M | 43.50M |
| Gross Profit | 10.70M | 9.58M | 9.14M | 7.19M | 6.81M |
| SG&A Expenses | 10.57M | 10.86M | 11.03M | 10.96M | 11.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.41M | 48.24M | 50.76M | 52.77M | 55.01M |
| Operating Income | 126.00K | -1.28M | -1.90M | -3.77M | -4.70M |
| Income Before Tax | 784.70K | -698.20K | -1.29M | -3.13M | -4.04M |
| Income Tax Expenses | 331.50K | -76.50K | -238.40K | -998.20K | -1.25M |
| Earnings from Continuing Operations | 0.45 | -0.62 | -1.05 | -2.13 | -2.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 453.20K | -621.70K | -1.05M | -2.13M | -2.79M |
| EBIT | 126.00K | -1.28M | -1.90M | -3.77M | -4.70M |
| EBITDA | 2.42M | 1.03M | 474.10K | -1.33M | -2.21M |
| EPS Basic | 0.51 | -0.70 | -1.17 | -2.38 | -3.12 |
| Normalized Basic EPS | 0.55 | -0.49 | -0.90 | -2.18 | -2.82 |
| EPS Diluted | 0.50 | -0.70 | -1.18 | -2.39 | -3.13 |
| Normalized Diluted EPS | 0.55 | -0.49 | -0.90 | -2.18 | -2.82 |
| Average Basic Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Average Diluted Shares Outstanding | 3.58M | 3.58M | 3.58M | 3.58M | 3.58M |
| Dividend Per Share | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Payout Ratio | 0.00% | -71.93% | -42.66% | -21.02% | -16.04% |